These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17416742)

  • 1. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors.
    Hemstapat K; Da Costa H; Nong Y; Brady AE; Luo Q; Niswender CM; Tamagnan GD; Conn PJ
    J Pharmacol Exp Ther; 2007 Jul; 322(1):254-64. PubMed ID: 17416742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression.
    Campo B; Kalinichev M; Lambeng N; El Yacoubi M; Royer-Urios I; Schneider M; Legrand C; Parron D; Girard F; Bessif A; Poli S; Vaugeois JM; Le Poul E; Celanire S
    J Neurogenet; 2011 Dec; 25(4):152-66. PubMed ID: 22091727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
    Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
    J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
    Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H
    J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
    Nikiforuk A; Popik P; Drescher KU; van Gaalen M; Relo AL; Mezler M; Marek G; Schoemaker H; Gross G; Bespalov A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):665-73. PubMed ID: 20739457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
    Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
    Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic nucleus.
    Hermes ML; Renaud LP
    J Pharmacol Exp Ther; 2011 Mar; 336(3):840-9. PubMed ID: 21139059
    [TBL] [